An International Open Access Journal
News Scroll
E-mail Alerts
Subscribe for TOC Alerts
Search Articles
sidebar
Creative Commons License

References


Adami S, Gatti D, Viapiana O, Fiore CE, Nuti R, Luisetto G, Ponte M, Rossini M, Bonturno Study Group (2008) Physical activity and bone turnover markers: a cross-sectional and a longitudinal study. Calcified Tissue International 83: 388-392. doi:10.1007/s00223-008-9184-8.

Aguirre JI, Plotkin LI, Stewart SA, Weinstein RS, Parfitt AM, Manolagas SC, Bellido T (2006) Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss. Journal of Bone and Mineral Research 21: 605-615. doi:10.1359/jbmr.060107.

AL-Balawi ZA, Sonbol HS, Aradwi MS (2017) Determination of Dickkopf-1 in serum of physically disabled Saudi girls and its correlation with BMI and bone turnover markers. Journal of American Science 13: 39-45.

Ardawi MS , Maimani AA , Bahksh TA , Rouzi AA , Qari MH , Raddadi RM (2010) Reference intervals of biochemical bone turnover markers for Saudi Arabian women: a cross-sectional study. Bone 47:804–814

Aronson E, Stevenson SB (2012) Bone health in children with cerebral palsy and epilepsy. Journal of Pediatric Health Care 26: 193-199. doi:10.1016/j.pedhc.2010.08.008.

Azcue MP, Zello GA, Levy LD, Pencharz PB (1996) Energy expenditure and body composition in children with spastic quadriplegic cerebral palsy. Journal of Pediatrics 129: 870–876. doi:10.1016/S0022-3476(96)70031-8.

Baroncelli GI, Bertelloni S, Sodini F, Saggese G (2005) Osteoporosis in children and adolescents: etiology and management. Pediatric Drugs 7: 295–323. doi:10.2165/00148581-200507050-00003.

Betts A M, Clark TH, Yang J, Treadway JL, Li M, Giovanelli M A,Abdiche Y, Stone DM, &Paralkar V M (2010). The application of target information and preclinical pharmacokinetic/pharmacodynamic modeling in predicting clinical doses of a Dickkopf-1 antibody for osteoporosis. Journal of Pharmacology and Experimental Therapeutics, 333(1), 2-13.‏

Bonewald LF (2011) The amazing osteocyte. Journal of Bone and Mineral Research 26: 229-238. doi:10.1002/jbmr.320.

Bonewald LF, Johnson ML (2008) Osteocytes, mechanosensing and Wnt signaling. Bone 42: 606-615. doi:10.1016/j.bone.2007.12.224.

Buehlmeier J, Frings-Meuthen P, Mohorko N, Lau P, Mazzucco S, Ferretti JL, Biolo G, Pisot R, Simunic B, Rittweger J (2017) Markers of bone metabolism during 14 days of bed rest in young and older men. Journal of Musculoskeletal and Neuronal Interactions 17: 399-408.

Butler JS, Queally JM, Devitt BM, Murray DW, Doran PP, O'Byrne JM (2010) Silencing Dkk1 expression rescues dexamethasone-induced suppression of primary human osteoblast differentiation. BMC Musculoskeletal Disorders 11: 210. doi:10.1186/1471-2474-11-210.

Choi HJ, Park H, Lee HW, Kwon YG (2012) The Wnt pathway and the roles for its antagonists, DKKS, in angiogenesis. IUBMB Life 64: 724–731. doi:10.1002/iub.1062.

Civitelli R, Armamento-Villareal R, Napoli N (2009) Bone turnover markers: understanding their value in clinical trials and clinical practice. Osteoporosis International 20: 843-851. doi:10.1007/s00198-009-0838-9.

Dahl M, Thommessen M, Rasmussen M, Selberg T (1996) Feeding and nutritional characteristics in children with moderate or severe cerebral palsy. Acta Paediatrica 85: 697–701. doi:10.1111/j.1651-2227.1996.tb14129.x.

Dahlseng MO, Finbråten AK, Júlíusson PB, Skranes J, Andersen G, Vik T (2012) Feeding problems, growth and nutritional status in children with cerebral palsy. Acta Paediatrica 101: 92–98. doi:10.1111/j.1651-2227.2011.02412.x.

Davies JH, Evans BAJ, Gregory JW (2005) Bone mass acquisition in healthy children. Archives of Disease in Childhood 90: 373-378. doi:10.1136/adc.2004.053553.

Delali? A, Kapidi?-Baši? N, Glinac A (2014) Body mass index in cerebral palsy patients with various motor severities. Paediatrics Today 10: 95-103. doi:10.5457/p2005-114.95.

Ray S, Khassawna TE, Sommer U, Thormann U, Wijekoon N, Lips K, Heiss C, Alt V (2017) Differences in expression of Wnt antagonist Dkk1 in healthy versus pathological bone samples. Journal of Microscopy 265: 111-120. doi:10.1111/jmi.12469

Diwan J, Diwan S, Bansal A (2014) Body mass index in children with cerebral palsy. National Journal of Integrated Research in Medicine 5: 40-45.

Dovjak P, Dorfer S, Föger-Samwald U, Kudlacek S, Marculescu R, Pietschmann P (2014) Serum levels of sclerostin and dickkopf-1: effects of age, gender and fracture status. Gerontology 60: 493-501. doi:10.1159/000358303.

Duran I, Schulze J, Martakis K, Stark C, Schoenau E (2018) Diagnostic performance of body mass index to identify excess body fat in children with cerebral palsy. Developmental Medicine and Child Neurology 60: 680–686. doi:10.1111/dmcn.13714.

Galli C, Piemontese M, Lumetti S, Manfredi E, Macaluso GM, Passeri G (2012) The importance of WNT pathways for bone metabolism and their regulation by implant topography. European Cells and Materials 24: 46-59. doi:10.22203/eCM.v024a04.

Gifre L, Vidal J, Carrasco JL, Filella X, Ruiz-Gaspà S, Muxi A, Portell E, Monegal A, Guañabens N, Peris P (2015) Effect of recent spinal cord injury on wnt signaling antagonists (sclerostin and dkk-1) and their relationship with bone loss. A 12-month prospective study. Journal of Bone and Mineral Research 30: 1014-1021. doi:10.1002/jbmr.2423.

Goksen D, Darcan S, Coker M, Kose T (2006) Bone mineral density of healthy Turkish children and adolescents. Journal of Clinical Densitometry 9: 84–90. doi:10.1016/j.jocd.2005.08.001.

Henderson RC, Lark RK, Gurka MJ, Worley G, Fung EB, Conaway M, Stallings VA, Stevenson RD (2002) Bone density and metabolism in children and adolescents with moderate to severe cerebral palsy. Pediatrics 110: e5. doi:10.1542/peds.110.1.e5.

Henriksen K, Christiansen C, Karsdal MA (2015) Role of biochemical markers in the management of osteoporosis. Climacteric 18: 10–18. doi:10.3109/13697137.2015.1101256.

Hillesund E, Skranes J, Trygg KU, Bøhmer T (2007) Micronutrient status in children with cerebral palsy. Acta Paediatrica 96: 1195–1198. doi:10.1111/j.1651-2227.2007.00354.x.

Hunter D, De Lange M, Snieder H, MacGregor AJ, Swaminathan R, Thakker RV, Spector TD (2001) Genetic contribution to bone metabolism, calcium excretion, and vitamin D and parathyroid hormone regulation. Journal of Bone and Mineral Research 16: 371-378. doi:10.1359/jbmr.2001.16.2.371.

Hurvitz EA, Green LB, Hornyak JE, Khurana SR, Koch LG (2008) Body mass index measures in children with cerebral palsy related to gross motor function classification: a clinic-based study. American Journal of Physical Medicine and Rehabilitation 87: 395-403. doi:10.1097/PHM.0b013e3181617736.

Ke HZ, Richards WG, Li X, Ominsky MS (2012) Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases. Endocrine Reviews 33: 747-783. doi:10.1210/er.2011-1060.

Kim W, Lee SJ, Yoon YK, Shin YK, Cho SR, Rhee Y (2015) Adults with spastic cerebral palsy have lower bone mass than those with dyskinetic cerebral palsy. Bone 71: 89-93.

Klein-Nulend J, Bakker AD, Bacabac RG, Vatsa A, Weinbaum S (2013) Mechanosensation and transduction in osteocytes. Bone 54: 182-190. doi:10.1016/j.bone.2012.10.013.

Li X, Grisanti M, Fan W, Asuncion FJ, Tan HL, Dwyer D, Han CY, Yu L, Lee J, Lee E, Barrero M, Kurimoto P, Niu QT, Geng Z, Winters A, Horan T, Steavenson S, Jacobsen F, Chen Q, Haldankar R, Lavallee J, Tipton B, Daris M, Sheng J, Lu HS, Daris K, Deshpande R, Valente EG, Salimi-Moosavi H, Kostenuik PJ, Li J, Liu M, Li C, Lacey DL, Simonet WS, Ke HZ, Babij P, Stolina M, Ominsky MS, Richards WG (2011) Dickkopf-1 regulates bone formation in young growing rodents and upon traumatic injury. Journal of Bone and Mineral Research 26: 2610–2621. doi:10.1002/jbmr.472.

Lin PP, Henderson RC (1996) Bone mineralization in the affected extremities of children with spastic hemiplegia. Developmental Medicine and Child Neurology 38: 782-786. doi:10.1111/j.1469-8749.1996.tb15112.x.

Mansour MMHK, Alhadidi KM (2012) Vitamin D deficiency in children living in Jeddah, Saudi Arabia. Indian Journal of Endocrinology and Metabolism 16: 263-269. doi:10.4103/2230-8210.93746.

Melunovic M, Hadzagic-Catibusic F, Bilalovic V, Rahmanovic S, Dizdar S (2017) Anthropometric parameters of nutritional status in children with cerebral palsy. Materia Socio-Medica 29: 68-72.doi:http://dx.doi.org.sdl.idm.oclc.org/10.5455/msm.2017.29.

Ministry of Health Saudi Arabia (2016) Musculoskeletal system diseases/ disability: reasons, types, treatment and rehabilitation/ what is disability? http://www.moh.gov.sa.

Morvan F, Boulukos K, Clément-Lacroix P, Roman Roman S, Suc-Royer I, Vayssière B, Ammann P, Martin P, Pinho S, Pognonec P, Mollat P, Niehrs C, Baron R, Rawadi G (2006) Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. Journal of Bone and Mineral Research 21: 934-945. doi:10.1359/jbmr.060311.

Niida A, Hiroko T, Kasai M, Furukawa Y, Nakamura Y, Suzuki Y, Sugano S, Akiyama T (2004) DKK1, a negative regulator of Wnt signaling, is a target of the β-catenin/TCF pathway. Oncogene 23: 8520-8526. doi:10.1038/sj.onc.1207892.

Pascoe J, Thomason P, Graham HK, Reddihough D, Sabin MA (2016) Body mass index in ambulatory children with cerebral palsy: a cohort study. Journal of Paediatrics and Child Health 52: 417-421. doi:10.1111/jpc.13097.

Quarles LD (2008) Endocrine functions of bone in mineral metabolism regulation. Journal of Clinical Investigation 118: 3820–3828. doi:10.1172/JCI36479.

Rachner TD, Thiele S, Göbel A, Browne A, Fuessel S, Erdmann K, Wirth MP, Fröhner M, Todenhöfer T, Muders MH, Kieslinger M, Rauner M, Hofbauer LC (2014) High serum levels of Dickkopf-1 are associated with a poor prognosis in prostate cancer patients. BMC Cancer 14: 649. doi:10.1186/1471-2407-14-649.

Ralston SH, Galwey N, MacKay I, Albagha OM, Cardon L, Compston JE, Cooper C, Duncan E, Keen R, Langdahl B, McLellan A, O’Riordan J, Pols HA, Reid DM, Uitterlinden AG, Wass J, Bennett ST (2005) Loci for regulation of bone mineral density in men and women identified by genome wide linkage scan: the FAMOS study. Human Molecular Genetics 14: 943–951. doi:10.1093/hmg/ddi088.

Rauchenzauner M, Schmid A, Heinz-Erian P, Kapelari K, Falkensammer G, Griesmacher A, Finkenstedt G, Högler W (2007) Sex- and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years. Journal of Clinical Endocrinology and Metabolism 92: 443-449. doi:10.1210/jc.2006-1706.

Holguin N, Brodt MD, Silva MJ (2016) Activation of Wnt Signaling by Mechanical Loading Is Impaired in the Bone of Old Mice. Journal of bone and mineral research?: the official journal of the American Society for Bone and Mineral Research 12:2215-2226. doi:10.1002/jbmr.2900.

Robling AG, Turner CH (2009) Mechanical signaling for bone modeling and remodeling. Critical Reviews in Eukaryotic Gene Expression 19: 319–338. doi:10.1615/CritRevEukarGeneExpr.v19.i4.50.

Roessler E, Du Y, Glinka A, Dutra A, Niehrs C, Muenke M (2000) The genomic structure, chromosome location, and analysis of the human DKK1 head inducer gene as a candidate for holoprosencephaly. Cytogenetics and Cell Genetics 89: 220–224. doi:10.1159/000015618.

Santos A, Bakker AD, Klein-Nulend J (2009) The role of osteocytes in bone mechanotransduction. Osteoporosis International 20: 1027-1031.

Sato Y, Fujimatsu Y, Kikuyama M, Kaji M, Oizumic K (1998) Influence of immobilization on bone mass and bone metabolism in hemiplegic elderly patients with a long-standing stroke. Journal of the Neurological Sciences 156: 205-210. doi:10.1016/S0022-510X(98)00041-0.

Shao YC, Wei Y, Liu JF, Xu XY (2017) The role of Dickkopf family in cancers: from Bench to Bedside. American Journal of Cancer Research 7: 1754-1768.

Shin YK, Yoon YK, Chung KB, Rhee Y, Cho SR (2017) Patients with non-ambulatory cerebral palsy have higher sclerostin levels and lower bone mineral density than patients with ambulatory cerebral palsy. Bone 103: 302-307. doi:10.1016/j.bone.2017.07.015.

Sullivan PB, Lambert B, Rose M, Ford-Adams M, Johnson A, Griffiths P (2000) Prevalence and severity of feeding and nutritional problems in children with neurological impairment: Oxford Feeding Study. Developmental Medicine and Child Neurology 42: 674-680. doi:10.1017/S0012162200001249.

Szulc P, Delmas PD (2008) Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis. Osteoporosis International 19: 1683–1704. doi:10.1007/s00198-008-0660-9.

Tasdemir HA, Buyukavci M , Akcay F , Polat P , Yildiran A, Karakelleoglu C (2001) Bone mineral density in children with cerebral palsy. Pediatrics International 43: 157-160. doi:10.1046/j.1442-200x.2001.01352.x.

Tella SH, Gallagher JC (2014) Biological agents in management of osteoporosis. European Journal of Clinical Pharmacology 70: 1291-1301. doi:10.1007/s00228-014-1735-5.

Unay B, Sarici SU, Vurucu S, Inanç N, Akin R, Gökçay E (2003) Evaluation of bone mineral density in children with cerebral palsy. Turkish Journal of Pediatrics 45: 11-14.

Vasilieva EM, Shor TA, Poddubnaia AE (2005) Changes of the thyroid hormone status in children with cerebral palsy and other neurological pathology. Zhurnalnevropatologiiipsikhiatriiimeni S.S. Korsakova (Moscow, Russia: 1952) 105: 10-14.

Verrotti A, Coppola G, Parisi P, Mohn A, Chiarelli F (2010) Bone and calcium metabolism and antiepileptic drugs. Clinical Neurology and Neurosurgery 112: 1–10. doi:10.1016/j.clineuro.2009.10.011.

Users Online: 41
Editorial Board
Indexed & Listed In
Track manuscript
Manuscript Statistics
Articles Statistics
Publication Statistics